Primary Erythromelalgia
2 clinical trials · Condition
◉ Watch Primary Erythromelalgia
| Record | Firm | Date |
|---|---|---|
| Phase 2a, Exploratory Study to Evaluate the Safety, Efficacy, Tolerability and Pharmacokinetics of XPF-002 in Patients With Primary/Inherited Erythromelalgia (NCT01486446) | Xenon Pharmaceuticals Inc. | 2011-12-01 |
| Study of XPF-001 in the Treatment of Pain From Primary/Inherited Erythromelalgia (IEM) (NCT01090622) | Xenon Pharmaceuticals Inc. | 2010-04-01 |
Track Primary Erythromelalgia automatically
Every clearance here is in the API, with alerts when new ones post.